High-risk Myelodysplastic Syndrome (MDS)
specific2
Centers
0
Active Trials
$515K
Cancer Funding
Top Centers for High-risk Myelodysplastic Syndrome (MDS)(2)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | NCI Comprehensive High-Volume Research Center | 83.8 |
| 2 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive | 66.2 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →